The Role of Narrow-Band Imaging Endoscopy in Diagnosing Gastric Intestinal Metaplasia

NCT00673699 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2008-05-07

No results posted yet for this study

Summary

The purpose of this study is to determine if endoscope with NBI(narrow banding imaging)can detect intestinal metaplasia( consider pre malignant condition) and use a targeting biopsy in case of suspected intestinal metaplasia

Conditions

  • Dyspepsia

Interventions

PROCEDURE

Gastric mucosal biopsy

Using upper gastrointestinal endoscopy with targeting biopsy in patients with dyspepsia

Sponsors & Collaborators

  • Hillel Yaffe Medical Center

    lead OTHER_GOV

Principal Investigators

  • Zvi Fireman, MD · Hillel Yaffe Med Ctr

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-01-31
Completion
2009-02-28

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00673699 on ClinicalTrials.gov